Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Total Liabilities (2017 - 2025)

Historic Total Liabilities for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to $27.5 million.

  • Cirtran's Total Liabilities rose 640.87% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 640.87%. This contributed to the annual value of $25.9 million for FY2024, which is 977.96% up from last year.
  • According to the latest figures from Q3 2025, Cirtran's Total Liabilities is $27.5 million, which was up 640.87% from $26.8 million recorded in Q2 2025.
  • Over the past 5 years, Cirtran's Total Liabilities peaked at $45.1 million during Q3 2023, and registered a low of $23.6 million during Q4 2023.
  • Its 5-year average for Total Liabilities is $35.9 million, with a median of $42.5 million in 2021.
  • As far as peak fluctuations go, Cirtran's Total Liabilities plummeted by 4638.16% in 2023, and later skyrocketed by 977.96% in 2024.
  • Quarter analysis of 5 years shows Cirtran's Total Liabilities stood at $42.0 million in 2021, then increased by 4.85% to $44.1 million in 2022, then plummeted by 46.38% to $23.6 million in 2023, then rose by 9.78% to $25.9 million in 2024, then rose by 5.87% to $27.5 million in 2025.
  • Its Total Liabilities stands at $27.5 million for Q3 2025, versus $26.8 million for Q2 2025 and $26.3 million for Q1 2025.